SlideShare a Scribd company logo
1 of 29
Infective Endocarditis
PRATIK KUMAR
080201186
Definition
Infection of the endocardial surface of heart characterized by
 - Colonization or invasion of the heart valves (native or
prosthetic) or the mural endocardium by a microbe,
 - leading to formation of bulky, friable vegetation composed
of thrombotic debris and organisms
 - often associated with destruction of underlying cardiac
tissue.
Sites involved
• Heart valves
• Ventricular septum defects
• Mural endocardium
• Intracardiac devices




• INFECTIVE ENDARTERITIS – analogus
Classification
 ACUTE ENDOCARDITIS               SUBACUTE ENDOCARDITIS

• Destructive and tumultuous      • Organisms of low virulence
  infection, frequently of a        causing infection in a
  previously normal heart           previously abnormal
  valve, with a highly virulent     heart, particularly on
  organism                          deformed valves.
• Hematogenoulsy seeds            • Disease appear insidiously and
                                    pursue a protracted course of
• If untreated, leads to death      weeks to month
  within weeks
                                  • Recover after appropriate
                                    antibiotic treatment
Predisposing factors
 CARDIAC AND VASCULAR ABNORMALITIES    HOST FACTORS

• RHD                                 • Neutropenia
• Myxomatous mitral valve             • Immunodeficiency
• Degenerative calcific valvular      • Malignancy
  stenosis                            • Therapeutic immunosuppression
• Bicuspid aortic valves              • Diabetes mellitus
• Prosthetic valves                   • Alcohol
                                      • IV drug abuse
Microbiology
• Staphylococcus aureus (35%) : Either healthy or deformed valves, IV drug
  abusers (polymicrobial), devices
• Streptococcus viridans (32%) : Native but previously damaged/abnormal
  valves
• Enterococci (8 %)
• CoNS - S. epidermidis (4%): Prosthetic valve endocarditis, devices
• G –ve bacilli of HACEK group (4%)
• Yeast and Fungi(1%)
• Culture negative endocarditis (5 %)
Pathogenesis
Portal of entry:
◦ Dental / Surgical Procedures
◦ Contamination by IV drug use
◦ Obvious infections (RS/Skin)
◦ Occult source from gut, oral cavity
◦ Trivial injuries.
◦ Intravascular catheter infection
◦ Nosocomial wounds
◦ Chronic invasive procedures
Endothelial Injury


    Uninfected Platelet-Fibrin thrombus (NBTE)

        Transient bacteremia and attachment at
        NBTE

            Proliferation and pro-coagulant state


                Infected, friable, bulky vegetation
Morphology
• Friable, bulky vegetation containing fibrin, inflammatory cells, and microbes
• Aortic and mitral valves involved most commonly.
• Right side valve involvement in iv drug users.
Clinical features
 Symptoms                        Constitutional symptoms


 - Damage    to intracardiac     --- Cytokine release ?
structures
  - Embolization of vegetation
fragments
 - Hematogenous infection
 - Immune complex
Sub-acute Endocarditis

• Persistent fever
• Constitutional symptoms
• New signs of valve
  dysfunction
• Heart failure



• Embolic Stroke
• Peripheral arterial
  embolism


• Other features
Modified Dukes Criteria for diagnosis
of Infective Endocarditis
    Definitive Endocarditis if,
    - Two major or,
    - One major and three minor or,
    - five minor


    Possible Endocarditis if,
    - One major and one minor or,
    - Three minor
Major Criteria
Positive blood culture
◦Typical organism from two cultures
◦Persistent positive blood cultures taken > 12 hours apart
◦Three or more positive cultures taken over more than 1
 hour.
Endocardial involvement
◦Positive echocardiographic findings of vegetations
◦New valvular regurgitation
Minor Criteria
• Predisposition: Predisposing valvular or cardiac abnormality
• Intravenous drug misuse
• Pyrexia ≥38°C (≥100.4°F)
• Embolic phenomenon
• Vasculitic/ immunologic phenomenon
• Blood cultures suggestive: -organism grown but not achieving
  major criteria
• Suggestive echocardiographic findings
INVESTIGATIO
NS
AVINASH BAJJURI
.
Microbiology
 Blood cultures:
Key diagnostic investigation in infective endocarditis.
Isolation of microorganism from culture is important for
 diagnosis and also for treatment.
At least 3 sets of samples should be taken from different
 venepuncture sites over 24 hours.
Serology
 Can be sent when the diagnosis is suspected and the
 cultures are negative.
They aid in cases where the organisms will not grow in
 blood cultures(Coxiella,Legionella,Bartonella)
ECG
 To detect complications like MI,conduction
abnormalities.
CHEST X RAY
.
Echocardiography
It can identify the presence and size of
 vegetations,detect intracardiac complications and
 assess cardiac function.
Transthoracic echocardiography is noninvasive and has
 high specificity for visualising vegetations.
Transoesophageal echocardiography is more sensitive
 than TTE.It can detect small vegetations,prosthetic
 endocarditis and intra cardiac complications.
.
Complete blood counts
  may show anamia and increased WBC counts.
Urea and Creatinine:
  may be elevated due to glomerulonephritis
Liver biochemistry:
   Serum alkaline phosphatase may be increased
Inflammatory markers
  CRP,ESR are increased in infection .CRP also helps in
 monotoring response to therapy.
Urine
   proteinuria and hematuria occur frequently.
TREATMENT
Antimicrobial Therapy
 Therapy requires identification of specific pathogen
 and its susceptibility to antimicrobials.
 Empirical therapy should be started as soon as
 possible targeting most likely pathogens.
 Bactericidal drugs should be used.
Resolution of fever occurs in 5 to 7 days.if fever
persists patient should be evaluated for complications
like paravalvular abscess and extracardiac abscess.
 Serologic abnormalities resolve slowly and do not
reflect response to treatment.
Antibotic regimen for infective endocarditis
 Streptococci
  Benzyl penicillin (1.2g 4 hourly) 4-6 weeks
  Gentamicin (1mg/kg 8-12 hourly) 4-6 weeks
Enterococci
o Ampicillin sensitive
   Ampicillin (2 g 4 hourly) 4-6 weeks, and
   Gentamicin (1mg/kg 8-12 hourly)
o Ampicillin resistant
   Vancomycin(1g 12hourly) 4-6 weeks, and
   Gentamicin (1mg/kg 8-12 hourly)
Staphycocci
oPenicillin sensitive
   Benzyl penicillin I.V(1.2 g 4 hourly)
oPenicillin resistant but methicillin sensitive
   Flucloxacillin I.V (2g 4 hourly )
oBoth penicillin and methicillin resistant
   Vancomycin I.V (1g 12 hourly) and
   Gentamicin
.
Surgery
 Indications
 patients with direct extension of infection to
 myocardial structuires.
Prosthetic valve dysfunction.
Congestive heart failure.
Badly damaged valves.
IE caused by fungi or gram-ve or resistant organisms.
Large vegetations on echocardiography
Recurrent embolic attacks.
Prophylaxis
  High risk category
 prosthetic cardiac valves
Previous bacterial endocarditis,even in absense of
 heart disease.
Complex cyanotic congenital heart disease(TGA,TOF)
 Surgically constructed systemic pulmonary shunts.
Moderate risk category
Rheumatic and other valvular dysfunction
Congenital cardiac malformations
Hypertrophic cardiomyopathy
Mitral valve prolapse with valvular regurgitation
Regimen for IE prophylaxis
 Standard oral regime
 Amoxicillin 2 g 1hr before procedure
 Inability to take oral medication
  Ampicillin 2g IV or IM 1hr before procedure
Penicillin allergy
  Clindamycin 600 mg
  Clarithromycin 500 mg
  Cephalexin 2 g.
Thank you.

More Related Content

What's hot

Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
Amith Kumar
 
Vasculitis Overview
Vasculitis OverviewVasculitis Overview
Vasculitis Overview
jcm MD
 
Diseases of the aorta
Diseases of the aortaDiseases of the aorta
Diseases of the aorta
Fuad Farooq
 

What's hot (20)

Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis pdf
Infective endocarditis pdfInfective endocarditis pdf
Infective endocarditis pdf
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 
Infective Endocarditis and It's Surgical Management
Infective Endocarditis and It's Surgical ManagementInfective Endocarditis and It's Surgical Management
Infective Endocarditis and It's Surgical Management
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Bacterial endocarditis
Bacterial  endocarditisBacterial  endocarditis
Bacterial endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis guidelines 2015
Infective endocarditis guidelines 2015Infective endocarditis guidelines 2015
Infective endocarditis guidelines 2015
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis 2020
Infective endocarditis 2020Infective endocarditis 2020
Infective endocarditis 2020
 
Acute Myocarditis:Diagnosis and Management
Acute Myocarditis:Diagnosis and ManagementAcute Myocarditis:Diagnosis and Management
Acute Myocarditis:Diagnosis and Management
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Vasculitis Overview
Vasculitis OverviewVasculitis Overview
Vasculitis Overview
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
 
Diseases of the aorta
Diseases of the aortaDiseases of the aorta
Diseases of the aorta
 

Viewers also liked

Infective endocarditis european guidlines 2012
Infective endocarditis european guidlines 2012Infective endocarditis european guidlines 2012
Infective endocarditis european guidlines 2012
Basem Enany
 
หน่วยการเรียนรู้ที่ ๖
หน่วยการเรียนรู้ที่ ๖หน่วยการเรียนรู้ที่ ๖
หน่วยการเรียนรู้ที่ ๖
Phonpat Songsomphao
 
השעה הפרטנית
השעה הפרטנית   השעה הפרטנית
השעה הפרטנית
Lea Patron
 
Butterfly
ButterflyButterfly
Butterfly
venuavs
 
愛的承諾Apo 2010年版com99080204
愛的承諾Apo 2010年版com99080204愛的承諾Apo 2010年版com99080204
愛的承諾Apo 2010年版com99080204
惠燕 蔡
 
System properties of random networks
System properties of random networksSystem properties of random networks
System properties of random networks
Marzieh Nabi
 
Projectm6 2-2554
Projectm6 2-2554Projectm6 2-2554
Projectm6 2-2554
Net'Net Zii
 

Viewers also liked (20)

Cvs ie-csbrp
Cvs ie-csbrpCvs ie-csbrp
Cvs ie-csbrp
 
Infective endocarditis european guidlines 2012
Infective endocarditis european guidlines 2012Infective endocarditis european guidlines 2012
Infective endocarditis european guidlines 2012
 
A Case of Infective Endocarditis
A Case of Infective EndocarditisA Case of Infective Endocarditis
A Case of Infective Endocarditis
 
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
2015 ESC Guidelines on Infective Endocarditis ppt. by Dr Abhishek Rathore MD
 
Pathology Review-Term1
Pathology Review-Term1Pathology Review-Term1
Pathology Review-Term1
 
หน่วยการเรียนรู้ที่ ๖
หน่วยการเรียนรู้ที่ ๖หน่วยการเรียนรู้ที่ ๖
หน่วยการเรียนรู้ที่ ๖
 
Cyber Worlds 2011 submission
Cyber Worlds 2011 submission Cyber Worlds 2011 submission
Cyber Worlds 2011 submission
 
All
AllAll
All
 
השעה הפרטנית
השעה הפרטנית   השעה הפרטנית
השעה הפרטנית
 
SHLOMO - VOL 1. August 2012 - UAE Edition
SHLOMO - VOL 1. August 2012 - UAE EditionSHLOMO - VOL 1. August 2012 - UAE Edition
SHLOMO - VOL 1. August 2012 - UAE Edition
 
Butterfly
ButterflyButterfly
Butterfly
 
Making Infrastructure as Awesome as Agile Development
Making Infrastructure as Awesome as Agile DevelopmentMaking Infrastructure as Awesome as Agile Development
Making Infrastructure as Awesome as Agile Development
 
愛的承諾Apo 2010年版com99080204
愛的承諾Apo 2010年版com99080204愛的承諾Apo 2010年版com99080204
愛的承諾Apo 2010年版com99080204
 
System properties of random networks
System properties of random networksSystem properties of random networks
System properties of random networks
 
6 матем
6 матем6 матем
6 матем
 
Network Identification via Node Knock-out
Network Identification via Node Knock-outNetwork Identification via Node Knock-out
Network Identification via Node Knock-out
 
Projectm6 2-2554
Projectm6 2-2554Projectm6 2-2554
Projectm6 2-2554
 
Aros Mini MBA - infomateriale om lederuddannelsen (minimba)
Aros Mini MBA - infomateriale om lederuddannelsen (minimba)Aros Mini MBA - infomateriale om lederuddannelsen (minimba)
Aros Mini MBA - infomateriale om lederuddannelsen (minimba)
 
Reinventing strategies for emerging markets
Reinventing strategies for emerging marketsReinventing strategies for emerging markets
Reinventing strategies for emerging markets
 
Poverty as a challenge
Poverty as a challenge Poverty as a challenge
Poverty as a challenge
 

Similar to Infective endocarditis

4. Infective endocarditis.pptx
4. Infective endocarditis.pptx4. Infective endocarditis.pptx
4. Infective endocarditis.pptx
TsionEnbelew
 

Similar to Infective endocarditis (20)

INFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITSINFECTIVE ENDOCARDITITS
INFECTIVE ENDOCARDITITS
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
INFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptxINFECTIVE ENDOCARDITIS FMCJ.pptx
INFECTIVE ENDOCARDITIS FMCJ.pptx
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis – an update
Infective endocarditis – an update Infective endocarditis – an update
Infective endocarditis – an update
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali Ebrahim
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali EbrahimInfective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali Ebrahim
Infective endocarditis by Dr. Basil Tumaini and Dr. Shamsherali Ebrahim
 
Infective endocarditis-CARDIO PPT.pptx
Infective endocarditis-CARDIO PPT.pptxInfective endocarditis-CARDIO PPT.pptx
Infective endocarditis-CARDIO PPT.pptx
 
Endocarditis april 2018
Endocarditis  april 2018Endocarditis  april 2018
Endocarditis april 2018
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
4. Infective endocarditis.pptx
4. Infective endocarditis.pptx4. Infective endocarditis.pptx
4. Infective endocarditis.pptx
 
Endocarditis and its management
Endocarditis and its managementEndocarditis and its management
Endocarditis and its management
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
2.3. IE.ppt
2.3. IE.ppt2.3. IE.ppt
2.3. IE.ppt
 
infectious endocarditis.pptx
infectious endocarditis.pptxinfectious endocarditis.pptx
infectious endocarditis.pptx
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 

More from Pratik Kumar

More from Pratik Kumar (20)

Tuberculin n scalp vein needle
Tuberculin n scalp vein needleTuberculin n scalp vein needle
Tuberculin n scalp vein needle
 
Treatment protocol of snake bite
Treatment protocol of snake biteTreatment protocol of snake bite
Treatment protocol of snake bite
 
Treatment of pda
Treatment of pdaTreatment of pda
Treatment of pda
 
Paeds
PaedsPaeds
Paeds
 
Paediatrics instruments
Paediatrics instrumentsPaediatrics instruments
Paediatrics instruments
 
Paediatric procedures part 2
Paediatric procedures part 2Paediatric procedures part 2
Paediatric procedures part 2
 
Paediatric procedures part 1
Paediatric procedures part 1Paediatric procedures part 1
Paediatric procedures part 1
 
Lumbar puncture and bone marrow aspiration
Lumbar puncture and bone marrow aspirationLumbar puncture and bone marrow aspiration
Lumbar puncture and bone marrow aspiration
 
Leprosy
LeprosyLeprosy
Leprosy
 
Laryngoscope
LaryngoscopeLaryngoscope
Laryngoscope
 
Laproscopy instruments
Laproscopy instrumentsLaproscopy instruments
Laproscopy instruments
 
Instruments ophthalmology
Instruments   ophthalmologyInstruments   ophthalmology
Instruments ophthalmology
 
Histoy
HistoyHistoy
Histoy
 
Hemoptysis
HemoptysisHemoptysis
Hemoptysis
 
Gc2 ascitis
Gc2  ascitisGc2  ascitis
Gc2 ascitis
 
Gc1 chd
Gc1  chdGc1  chd
Gc1 chd
 
Gc hydrocephalus
Gc  hydrocephalusGc  hydrocephalus
Gc hydrocephalus
 
Endotracheal tubes
Endotracheal tubesEndotracheal tubes
Endotracheal tubes
 
Ecg !
Ecg !Ecg !
Ecg !
 
Chest x rays
Chest x raysChest x rays
Chest x rays
 

Infective endocarditis

  • 2. Definition Infection of the endocardial surface of heart characterized by - Colonization or invasion of the heart valves (native or prosthetic) or the mural endocardium by a microbe, - leading to formation of bulky, friable vegetation composed of thrombotic debris and organisms - often associated with destruction of underlying cardiac tissue.
  • 3. Sites involved • Heart valves • Ventricular septum defects • Mural endocardium • Intracardiac devices • INFECTIVE ENDARTERITIS – analogus
  • 4. Classification ACUTE ENDOCARDITIS SUBACUTE ENDOCARDITIS • Destructive and tumultuous • Organisms of low virulence infection, frequently of a causing infection in a previously normal heart previously abnormal valve, with a highly virulent heart, particularly on organism deformed valves. • Hematogenoulsy seeds • Disease appear insidiously and pursue a protracted course of • If untreated, leads to death weeks to month within weeks • Recover after appropriate antibiotic treatment
  • 5. Predisposing factors CARDIAC AND VASCULAR ABNORMALITIES HOST FACTORS • RHD • Neutropenia • Myxomatous mitral valve • Immunodeficiency • Degenerative calcific valvular • Malignancy stenosis • Therapeutic immunosuppression • Bicuspid aortic valves • Diabetes mellitus • Prosthetic valves • Alcohol • IV drug abuse
  • 6. Microbiology • Staphylococcus aureus (35%) : Either healthy or deformed valves, IV drug abusers (polymicrobial), devices • Streptococcus viridans (32%) : Native but previously damaged/abnormal valves • Enterococci (8 %) • CoNS - S. epidermidis (4%): Prosthetic valve endocarditis, devices • G –ve bacilli of HACEK group (4%) • Yeast and Fungi(1%) • Culture negative endocarditis (5 %)
  • 7. Pathogenesis Portal of entry: ◦ Dental / Surgical Procedures ◦ Contamination by IV drug use ◦ Obvious infections (RS/Skin) ◦ Occult source from gut, oral cavity ◦ Trivial injuries. ◦ Intravascular catheter infection ◦ Nosocomial wounds ◦ Chronic invasive procedures
  • 8. Endothelial Injury Uninfected Platelet-Fibrin thrombus (NBTE) Transient bacteremia and attachment at NBTE Proliferation and pro-coagulant state Infected, friable, bulky vegetation
  • 9. Morphology • Friable, bulky vegetation containing fibrin, inflammatory cells, and microbes • Aortic and mitral valves involved most commonly. • Right side valve involvement in iv drug users.
  • 10. Clinical features Symptoms Constitutional symptoms - Damage to intracardiac --- Cytokine release ? structures - Embolization of vegetation fragments - Hematogenous infection - Immune complex
  • 11. Sub-acute Endocarditis • Persistent fever • Constitutional symptoms • New signs of valve dysfunction • Heart failure • Embolic Stroke • Peripheral arterial embolism • Other features
  • 12.
  • 13. Modified Dukes Criteria for diagnosis of Infective Endocarditis Definitive Endocarditis if, - Two major or, - One major and three minor or, - five minor Possible Endocarditis if, - One major and one minor or, - Three minor
  • 14. Major Criteria Positive blood culture ◦Typical organism from two cultures ◦Persistent positive blood cultures taken > 12 hours apart ◦Three or more positive cultures taken over more than 1 hour. Endocardial involvement ◦Positive echocardiographic findings of vegetations ◦New valvular regurgitation
  • 15. Minor Criteria • Predisposition: Predisposing valvular or cardiac abnormality • Intravenous drug misuse • Pyrexia ≥38°C (≥100.4°F) • Embolic phenomenon • Vasculitic/ immunologic phenomenon • Blood cultures suggestive: -organism grown but not achieving major criteria • Suggestive echocardiographic findings
  • 17. . Microbiology  Blood cultures: Key diagnostic investigation in infective endocarditis. Isolation of microorganism from culture is important for diagnosis and also for treatment. At least 3 sets of samples should be taken from different venepuncture sites over 24 hours.
  • 18. Serology  Can be sent when the diagnosis is suspected and the cultures are negative. They aid in cases where the organisms will not grow in blood cultures(Coxiella,Legionella,Bartonella) ECG To detect complications like MI,conduction abnormalities. CHEST X RAY
  • 19. . Echocardiography It can identify the presence and size of vegetations,detect intracardiac complications and assess cardiac function. Transthoracic echocardiography is noninvasive and has high specificity for visualising vegetations. Transoesophageal echocardiography is more sensitive than TTE.It can detect small vegetations,prosthetic endocarditis and intra cardiac complications.
  • 20. . Complete blood counts may show anamia and increased WBC counts. Urea and Creatinine: may be elevated due to glomerulonephritis Liver biochemistry: Serum alkaline phosphatase may be increased Inflammatory markers CRP,ESR are increased in infection .CRP also helps in monotoring response to therapy. Urine proteinuria and hematuria occur frequently.
  • 21. TREATMENT Antimicrobial Therapy Therapy requires identification of specific pathogen and its susceptibility to antimicrobials. Empirical therapy should be started as soon as possible targeting most likely pathogens. Bactericidal drugs should be used.
  • 22. Resolution of fever occurs in 5 to 7 days.if fever persists patient should be evaluated for complications like paravalvular abscess and extracardiac abscess. Serologic abnormalities resolve slowly and do not reflect response to treatment.
  • 23. Antibotic regimen for infective endocarditis  Streptococci Benzyl penicillin (1.2g 4 hourly) 4-6 weeks Gentamicin (1mg/kg 8-12 hourly) 4-6 weeks Enterococci o Ampicillin sensitive Ampicillin (2 g 4 hourly) 4-6 weeks, and Gentamicin (1mg/kg 8-12 hourly) o Ampicillin resistant Vancomycin(1g 12hourly) 4-6 weeks, and Gentamicin (1mg/kg 8-12 hourly)
  • 24. Staphycocci oPenicillin sensitive Benzyl penicillin I.V(1.2 g 4 hourly) oPenicillin resistant but methicillin sensitive Flucloxacillin I.V (2g 4 hourly ) oBoth penicillin and methicillin resistant Vancomycin I.V (1g 12 hourly) and Gentamicin
  • 25. . Surgery Indications  patients with direct extension of infection to myocardial structuires. Prosthetic valve dysfunction. Congestive heart failure. Badly damaged valves. IE caused by fungi or gram-ve or resistant organisms. Large vegetations on echocardiography Recurrent embolic attacks.
  • 26. Prophylaxis High risk category  prosthetic cardiac valves Previous bacterial endocarditis,even in absense of heart disease. Complex cyanotic congenital heart disease(TGA,TOF)  Surgically constructed systemic pulmonary shunts.
  • 27. Moderate risk category Rheumatic and other valvular dysfunction Congenital cardiac malformations Hypertrophic cardiomyopathy Mitral valve prolapse with valvular regurgitation
  • 28. Regimen for IE prophylaxis Standard oral regime Amoxicillin 2 g 1hr before procedure Inability to take oral medication Ampicillin 2g IV or IM 1hr before procedure Penicillin allergy Clindamycin 600 mg Clarithromycin 500 mg Cephalexin 2 g.